85 related articles for article (PubMed ID: 657132)
21. [Premature ovarian insufficiency induced by alkylating agents (author's transl)].
Güitrón A; Martínez G; Forsbach G; Muñoz M; Joffre G; Galache P; Hernández-Ayup S
Rev Invest Clin; 1982; 34(1):59-61. PubMed ID: 7089401
[No Abstract] [Full Text] [Related]
22. Differential effects of cytotoxic agents on hematopoietic progenitors.
Botnick LE; Hannon EC; Vigneulle R; Hellman S
Cancer Res; 1981 Jun; 41(6):2338-42. PubMed ID: 7237432
[TBL] [Abstract][Full Text] [Related]
23. [Alkylating cytostatic agents].
Schmidt CG
Internist (Berl); 1971; 12():Suppl 1:119-27. PubMed ID: 5002874
[No Abstract] [Full Text] [Related]
24. [Carcinogenic effects of anti neoplastic and immunosuppressive drugs].
Brock N; Schneider B
Arzneimittelforschung; 1971 Apr; 21(4):435-43. PubMed ID: 5108136
[No Abstract] [Full Text] [Related]
25. An in vitro clonal assay of adherent stem cells (ASC) in mouse marrow.
Reincke U; Rosenblatt M; Hellman S
J Cell Physiol; 1984 Nov; 121(2):275-83. PubMed ID: 6490726
[TBL] [Abstract][Full Text] [Related]
26. In vitro expansion of murine hematopoietic progenitor cells in liquid cultures for bone marrow transplantation: effects of stem cell factor.
Han M; Kobayashi M; Imamura M; Hashino S; Kobayashi H; Maeda S; Iwasaki H; Fujii Y; Musashi M; Sakurada K
Int J Hematol; 1993 Apr; 57(2):113-20. PubMed ID: 7684269
[TBL] [Abstract][Full Text] [Related]
27. [Heterogeneity of splenic colonies formed by clonogenic hematopoietic cells of embryonic liver].
Domaratskaia EI; Prianishnikova OD; Starostin VI; Sokolova EA; Khrushchov NG
Dokl Akad Nauk SSSR; 1985; 281(5):1216-8. PubMed ID: 3891275
[No Abstract] [Full Text] [Related]
28. Hematopoietic precursor cell exhaustion is a cause of proliferative defect in primitive hematopoietic stem cells (PHSC) after chemotherapy.
Gardner RV; Astle CM; Harrison DE
Exp Hematol; 1997 Jun; 25(6):495-501. PubMed ID: 9197327
[TBL] [Abstract][Full Text] [Related]
29. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
[TBL] [Abstract][Full Text] [Related]
30. Implications of a proliferative limitation on hematopoietic stem cells.
Hellman S; Mauch P
Prog Clin Biol Res; 1984; 148():51-8. PubMed ID: 6379673
[No Abstract] [Full Text] [Related]
31. Different recovery patterns of mouse haemopoietic stem cells in response to cytotoxic agents.
Blackett NM; Millard RE
J Cell Physiol; 1976 Nov; 89(3):473-80. PubMed ID: 977663
[TBL] [Abstract][Full Text] [Related]
32. Biologic effects of prolonged melphalan treatment of murine long-term bone marrow cultures and interleukin 3-dependent hematopoietic progenitor cell lines.
Greenberger JS; Palaszynski EW; Pierce JH; Sakakeeny MA; Ruscetti SK; Ihle JN; Daugherty C
J Natl Cancer Inst; 1985 Jan; 74(1):247-62. PubMed ID: 3918212
[TBL] [Abstract][Full Text] [Related]
33. Preclinical studies and clinical correlation of the effect of alkylating dose.
Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
[TBL] [Abstract][Full Text] [Related]
34. Effect of myleran on murine hemopoiesis. II. Direct and host-mediated action on proliferative capacity and differentiation bias of spleen colony forming units (CFU-S).
Delmonte L
Cell Tissue Kinet; 1978 Jul; 11(4):359-67. PubMed ID: 688327
[No Abstract] [Full Text] [Related]
35. Triggering of stem cell (CFU-S) proliferation after transplantation into irradiated hosts.
Necas E
Exp Hematol; 1992 Oct; 20(9):1146-8. PubMed ID: 1468547
[TBL] [Abstract][Full Text] [Related]
36. [Disorders of bone marrow hematopoiesis long time after the action of cytostatic preparations].
Bogdashin IV; Sycheva EV; Zhdanov VV; Afanas'eva ON; Zapuskalova OP; Novitskiĭ VV; Gol'dberg ED
Biull Eksp Biol Med; 1992 Mar; 113(3):283-4. PubMed ID: 1421227
[TBL] [Abstract][Full Text] [Related]
37. [Self-maintenance and the proliferative activity of hematopoietic stroma precursor cells].
Gurevich OA; Chertkov IL
Probl Gematol Pereliv Krovi; 1980 Feb; 25(2):3-7. PubMed ID: 6987646
[No Abstract] [Full Text] [Related]
38. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
van Os R; Robinson S; Sheridan T; Mauch PM
Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
[TBL] [Abstract][Full Text] [Related]
39. [Correction of changes in populations of hematopoietic progenitor cells induced by testosterone using an inhibitor of cellular proliferative activity of hematopoietic stem cells].
Orlovskaia IA; Khaldoianidi SK; Shklovskaia EV; Tsyrlova IG; Kozlov VA
Biull Eksp Biol Med; 1995 Oct; 120(10):394-7. PubMed ID: 8595230
[No Abstract] [Full Text] [Related]
40. Sex steroid ablation enhances hematopoietic recovery following cytotoxic antineoplastic therapy in aged mice.
Dudakov JA; Goldberg GL; Reiseger JJ; Vlahos K; Chidgey AP; Boyd RL
J Immunol; 2009 Dec; 183(11):7084-94. PubMed ID: 19890044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
